Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post on LinkedIn:
“First DAY! 1st International Symposium ctDNA-RECIST! Very well attended! +/- 100 participants!
Delighted to attend the First International Symposium on ctDNA-RECIST (Response Evaluation Criteria in Solid Tumors) – 14-15 March, 2025 in Aarhus, Denmark organized by Karen-Lise Garm Spindler.
Many key points will be discussed:
- Why can ctDNA-RECIST change oncology?
- ctDNA Analysis – What clinicians must know.
- ctDNA data in metastatic cancers – how far are we?
- Defining ctDNA-response criteria
- Trial designs and study examples
- Workshop session – Clinical trial design.”
